Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
for
Diabetes Mellitus, Type 1
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 65
Code: NCT06503809
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: St Louis MO, Louisville KY, Little Rock AR,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: St Louis MO, Kansas City MO, Nashville TN, Chicago IL,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: St Louis MO, Peoria IL, Oak Lawn IL, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
for
Carotid Artery Diseases
Location: Saint Louis MO, Indianapolis IN, Cincinnati OH,
Sponsor: InspireMD
Sex: All
Age: 18 - 70+
Code: NCT06653387
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: St Louis MO, Weldon Spring MO, Indianapolis IN,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase3, Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: St Louis MO, Westwood KS, Nashville TN, Madison WI,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
for
Delirium
Location: St Louis MO, Iowa City IA, Nashville TN, Chicago IL,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 60+
Code: NCT06192615
Phase3, Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Location: St Louis MO, Indianapolis IN, Flowood MS, Dallas TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05519475
Phase2, Recruiting
Cryoablation vs Lumpectomy in T1 Breast Cancers
for
Breast Cancer, Breast Neoplasm
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 50+
Code: NCT05505643
Recruiting
Endometriosis Pain
for
Pelvic Pain, Endometriosis
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 12 - 45
Code: NCT06101303
Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
for
Lymphatic Malformations
Location: St Louis MO, Cincinnati OH, Columbus OH, Cleveland OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT05948943
Phase2, Phase3, Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: St Louis MO, Kansas City MO, Nashville TN, Chicago IL,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase1, Phase2, Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer